CoChat

Youth-Onset Type 2 Diabetes Mellitus: Lessons Learned From the TODAY Study

Open access
Narasimhan, Sumana, Weinstock, Ruth S. · 2014 · Mayo Clinic Proceedings
Cited by 95

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes is increasingly diagnosed in obese children and adolescents. Evidence suggests that this disease commonly progresses more rapidly in youth compared to adults, and is associated with high rates of early microalbuminuria, hypertension and dyslipidemia. The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study was the first multiethnic, multicenter randomized trial in the United States to compare three treatment approaches in new onset type 2 diabetes in obese youth (n=699; ages 10–17): monotherapy with metformin, metformin with roziglitazone, and metformin with an intensive lifestyle intervention. The primary outcome was glycemic control. Diabetes-related complications and cardiovascular risk factors were also examined. Approximately half of the participants were unable to maintain glycemic control using metformin alone. Combination therapy of metformin with rosiglitazone resulted in better durability of glycemic control, and the metformin plus intensive lifestyle was intermediate but not superior to metformin alone. Deterioration in glycemic control was associated with rapid loss of beta cell function, not worsened insulin sensitivity, and could not be explained by differences in adherence or BMI. After 3.9 years, 33.8% of participants had hypertension and 16.6% had microalbuminuria. Only 55.9% of participants had an LDL-cholesterol <100 mg/dl after 3 years and 13.7% had retinopathy. The significance of the findings from this important trial for the management of youth and young adults with youth-onset type 2 diabetes and its complications is discussed. An aggressive multifaceted approach is needed to prevent or forestall premature microvascular and macrovascular complications in youth-onset type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mayocp.2014.01.009

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 95

Metadata

Authors
Narasimhan, S., & Weinstock, R. S.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2014-06
Volume
89
Issue
6
Pages
806-816
ISSN
0025-6196 (ISSN-L)
OpenAlex
W2161737636
Cited by
95
References
11
FWCI
9.10
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Youth-Onset Type 2 Diabetes Mellitus: Lessons Learned From the TODAY Study. https://app.cochat.ai/papers/10.1016/j.mayocp.2014.01.009
The paper
Narasimhan, S., & Weinstock, R. S. (2014). Youth-Onset Type 2 Diabetes Mellitus: Lessons Learned From the TODAY Study. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2014.01.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.